Patents by Inventor Paul T. Jubinsky

Paul T. Jubinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to MAGMAS and uses thereof
    Publication number: 20090155172
    Abstract: The present invention relates to isolated and purified Magmas protein, isolated and purified nucleic acids encoding Magmas protein, and antibodies to Magmas protein, which interacts with granulocyte macrophage colony stimulating factor (GM-CSF). More specifically, the invention relates to uses of such anti-Magmas antibodies. The invention further relates to a method for diagnosis, prognosis and treatment of diseases, particularly, cancer, Alzheimer's disease and mitochondrial diseases using Magmas sequences and antibodies directed against the Magmas protein or fragments thereof.
    Type: Application
    Filed: January 26, 2008
    Publication date: June 18, 2009
    Inventors: Mary K. Short, Paul T. Jubinsky
  • Antibodies to magmas and uses thereof
    Patent number: 7358041
    Abstract: The present invention relates to isolated and purified Magmas protein, isolated and purified nucleic acids encoding Magmas protein, and antibodies to Magmas protein, which interacts with granulocyte macrophage colony stimulating factor (GM-CSF). More specifically, the invention relates to uses of such anti-Magmas antibodies. The invention further relates to a method for diagnosis, prognosis and treatment of diseases, particularly, cancer, Alzheimer's disease and mitochondrial diseases using Magmas sequences and antibodies directed against the Magmas protein or fragments thereof.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: April 15, 2008
    Inventors: Mary K. Short, Paul T. Jubinsky
  • Antibodies for GM-CSF receptor and uses thereof
    Patent number: 5932704
    Abstract: Antibodies capable of binding to the a subunit of the human GM-CSF receptor are described. These antibodies can inhibit the proliferation of cells whose growth is dependent upon the presence of human GM-CSF. Methods of assaying for the human GM-CSF receptor are also disclosed.
    Type: Grant
    Filed: January 25, 1995
    Date of Patent: August 3, 1999
    Assignee: Dana-Farber Cancer Institute
    Inventor: Paul T. Jubinsky